Blossom Health, a New York-based telepsychiatry startup established in 2024, has successfully secured $20 million in a combined seed and Series A funding round. This significant investment is intended to accelerate the expansion of its cutting-edge AI-powered platform. The platform is designed to equip psychiatrists with clinical AI copilots and provide comprehensive automated administrative support, thereby streamlining mental healthcare delivery.
The funding initiative was led by Headline, a prominent venture capital firm. Demonstrating their commitment, Mathias Schilling, co-founder and managing partner at Headline, will be taking a seat on Blossom Health’s board of directors, contributing to the company’s strategic direction and growth.
